Gladys Morrison Thiele

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Carolina BioOncology Institute(Current)

Tokyo National Hospital

South Texas Accelerated Research Therapeutics

National Cancer Center Hospital East

AbbVie (United States)

Gladys Morrison Thiele is an author at Carolina BioOncology Institute specializing in oncology, antibody-drug conjugate pharmacokinetics, and antibody-drug conjugate antibodies.

Publications per year

2023–2024

Publications

First-in-human study of ABBV-400, a novel c-Met–targeting antibody-drug conjugate, in advanced solid tumors: Results in colorectal cancer.

Manish Sharma, John H. Strickler, David Sommerhalder et al. · Journal of Clinical Oncology · 2024 · 16 citations

Medicine, Oncology, Pharmacology +17

Dose escalation results from a first-in-human study of ABBV-400, a novel c-Met–targeting antibody-drug conjugate, in advanced solid tumors.

Manish Sharma, Yasutoshi Kuboki, D. Ross Camidge et al. · Journal of Clinical Oncology · 2023 · 12 citations

Pharmacy, Oncology, Pharmacology +17

1–2 of 2